The Scleroderma Foundation has named Lesley Ann Saketkoo, MD, as Doctor of the Year. This award is granted to leaders…
Articles by Iqra Mumal, MSc
Malakoplakia, a rare granulomatous disorder, was reported for the first time in a patient with systemic sclerosis in a recent…
Genes and microRNAs that are a part of cancer-promoting signaling pathways are also overly active in systemic sclerosis (SSc) patients,…
Blood serum levels of the protein CD163 may be a potential biomarker to identify patients with systemic sclerosis,…
In patients with systemic sclerosis, renal function is generally well-preserved, despite increased stiffness of the arteries that supply the…
Changes in gene expression occur early in scleroderma patients with pulmonary arterial hypertension or interstitial lung disease, which means that…
Boehringer Ingelheim‘s product nintedanib (marketed as Ofev for the treatment of idiopathic pulmonary fibrosis) has been granted fast…
The U.S. Food and Drug Administration (FDA) has agreed to allow Fibrocell Science to begin clinical trials testing its…
The European Medicines Agency has granted orphan drug designation to Emerald Health Pharmaceuticals’  lead cannabis-based product for treating systemic scleroderma.
Fibrocell Science has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for…